ArticleHaematologica2019

Correction of IVS I-110(G>A) β-thalassemia by CRISPR/Cas-and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cells.

Petros Patsali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.